Home
Home

Enbrel

Will Generic Competitors Of Enbrel Affect Amgen's Stock Price?

Will Generic Competitors Of Enbrel Affect Amgen's Stock Price?
Seeking Alpha

Celgene: Apremilast For Psoriatic Arthritis Offers Upside

Celgene: Apremilast For Psoriatic Arthritis Offers Upside
Seeking Alpha

Enbrel's Asian Biosimilar Competitors

Enbrel's Asian Biosimilar Competitors
Seeking Alpha

Cipla steamrolls into Enbrel market with biosimilar of Amgen drug

Cipla steamrolls into Enbrel market with biosimilar of Amgen drug
Fierce Pharma

Is Celgene's Apremilast A Potential Blockbuster Or Not?

Is Celgene's Apremilast A Potential Blockbuster Or Not?
Seeking Alpha

Can New Psoriasis Drugs Scratch Investors' Itch?

Can New Psoriasis Drugs Scratch Investors' Itch?
Investors.com

Can JAK Inhibitors Challenge Biologics?

Can JAK Inhibitors Challenge Biologics?
Motley Fool

Can Ampio's New Science Take A Big Bite Out Of The $60 Billion Anti-Inflammatory Market?

Can Ampio's New Science Take A Big Bite Out Of The $60 Billion Anti-Inflammatory Market?
Seeking Alpha

Amgen To Assume Certain Pfizer Sales Duties For Enbrel In US

Amgen To Assume Certain Pfizer Sales Duties For Enbrel In US
NASDAQ.com

New Patent Could Be Worth $6 A Share To Amgen

New Patent Could Be Worth $6 A Share To Amgen
Forbes